Table 2 Incidence of invasive fungal infections in acute lymphoblastic or acute myelogenous leukemia with or without prophylactic antimold agents.

From: Incidence of invasive fungal infection in acute lymphoblastic and acute myelogenous leukemia in the era of antimold prophylaxis

 

IFI episodes

OR (95% CI) (vs. AML with prophylaxis)

AML without prophylaxis (n = 173)

15 (8.7)

1.51 (0.70–3.27)*

ALL without prophylaxis (n = 148)

12 (8.1)

1.41 (0.62–3.17)*

AML with prophylaxis (n = 220)

13 (5.9)

–

ALL with prophylaxis (n = 11)

0 (0.0)

NA

  1. * P > 0.05.
Back to article page